Former pharmaceutical executive Martin Shkreli must remain in prison for securities fraud, a federal appeals court ruled Thursday. Shkreli is seen here in 2017, speaking after the jury reached a verdict in his case at the U.S. District Court for the Eastern District of New York in Brooklyn